388 related articles for article (PubMed ID: 24427316)
1. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care.
Müllerová H; Lu C; Li H; Tabberer M
PLoS One; 2014; 9(1):e85540. PubMed ID: 24427316
[TBL] [Abstract][Full Text] [Related]
2. Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study.
Punekar YS; Wurst K; Shukla A
COPD; 2015 Jun; 12(3):267-75. PubMed ID: 25093809
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.
Müllerová H; Shukla A; Hawkins A; Quint J
BMJ Open; 2014 Dec; 4(12):e006171. PubMed ID: 25524545
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of first-recorded breathlessness for future chronic respiratory and heart disease: a cohort study using a UK national primary care database.
Chen Y; Hayward R; Chew-Graham CA; Hubbard R; Croft P; Sims K; Jordan KP
Br J Gen Pract; 2020 Apr; 70(693):e264-e273. PubMed ID: 32041768
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Bestall JC; Paul EA; Garrod R; Garnham R; Jones PW; Wedzicha JA
Thorax; 1999 Jul; 54(7):581-6. PubMed ID: 10377201
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey.
Barnes N; Calverley PM; Kaplan A; Rabe KF
BMC Pulm Med; 2013 Aug; 13():54. PubMed ID: 23971625
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
[TBL] [Abstract][Full Text] [Related]
8. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
Punekar YS; Shukla A; Müllerova H
Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
[TBL] [Abstract][Full Text] [Related]
9. Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care.
Tupper OD; Kjeldgaard P; Løkke A; Ulrik CS
Chron Respir Dis; 2018 Nov; 15(4):393-399. PubMed ID: 29486583
[TBL] [Abstract][Full Text] [Related]
10. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
[TBL] [Abstract][Full Text] [Related]
12. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
[TBL] [Abstract][Full Text] [Related]
13. Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.
Sundh J; Bornefalk H; Sköld CM; Janson C; Blomberg A; Sandberg J; Bornefalk-Hermansson A; Igelström H; Ekström M
BMJ Open Respir Res; 2019; 6(1):e000418. PubMed ID: 31673362
[TBL] [Abstract][Full Text] [Related]
14. Dyspnoea and mortality in older people in the community: a 10-year follow-up.
Ahmed T; Steward JA; O'Mahony MS
Age Ageing; 2012 Jul; 41(4):545-9. PubMed ID: 22522776
[TBL] [Abstract][Full Text] [Related]
15. The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients.
Paladini L; Hodder R; Cecchini I; Bellia V; Incalzi RA
Respir Med; 2010 Jul; 104(7):1027-34. PubMed ID: 20116231
[TBL] [Abstract][Full Text] [Related]
16. Persistent disabling breathlessness in chronic obstructive pulmonary disease.
Sundh J; Ekström M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2805-2812. PubMed ID: 27877034
[TBL] [Abstract][Full Text] [Related]
17. The relationship between sleep quality and dyspnoea severity in patients with COPD.
Serin EK; Ister ED; Ozdemir A
Afr Health Sci; 2020 Dec; 20(4):1785-1792. PubMed ID: 34394240
[TBL] [Abstract][Full Text] [Related]
18. Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease.
Demircioğlu H; Cihan FG; Kutlu R; Yosunkaya Ş; Zamani A
Turk J Med Sci; 2020 Aug; 50(5):1270-1279. PubMed ID: 32421282
[TBL] [Abstract][Full Text] [Related]
19. Individualized breathlessness interventions may improve outcomes in patients with advanced COPD.
Qian MYY; Politis J; Thompson M; Wong D; Le B; Irving L; Smallwood N
Respirology; 2018 Dec; 23(12):1146-1151. PubMed ID: 29763515
[TBL] [Abstract][Full Text] [Related]
20. Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD.
Javadzadeh S; Chowienczyk S; Booth S; Farquhar M
BMJ Support Palliat Care; 2016 Mar; 6(1):105-8. PubMed ID: 26685116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
